Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,38
KB-1,24
PKN109,35106,2-0,05
Msft2,55
IBM-0,97
DCX70,9570,980,17
PFE2,03
16.12.2017 2:10:00
Indexy online
AD Index online
select
AD Index online
 

  • 15.12.2017
Inogen (NASDAQ Cons)
Závěr k 15.12.2017 Změna (%) Změna (USD) Objem obchodů (ks)
122,12 2,20 2,63 409 485
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 16.12.2017
Popis společnosti
Obecné informace
Název společnostiInogen Inc
TickerINGN
Kmenové akcie:Ordinary Shares
RICINGN.O
ISINUS45780L1044
Poslední známé roční výsledky31.12.2016
Poslední známé čtvrtletní výsledky30.9.2017
Počet zaměstnanců k 31.12.2016 602
Akcie v oběhu k 30.9.2017 20 851 696
Počet akcionářů k 31.12.2016 18
MěnaUSD
Konstituent indexůS&P 600 Small Cap
Kontaktní informace
Ulice326 Bollay Dr
MěstoGOLETA
PSČ93117-5550
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon18 055 620 500
Fax13026365454

Business Summary: Inogen, Inc. is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device. Its three portable product offerings, the Inogen One G4, Inogen One G3 and Inogen One G2, at approximately 2.8, 4.8 and 7.0 pounds with a single battery, respectively. Its Inogen One G4, Inogen One G3 and Inogen One G2 are sub-3, sub-5 and sub-10 pound portable oxygen concentrators, respectively. All of its Inogen One systems are equipped with Intelligent Delivery Technology. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory oxygen patient market and serves as a backup to its Inogen One system for ambulatory patients on its rental service.
Financial Summary: BRIEF: For the nine months ended 30 September 2017, Inogen Inc revenues increased 22% to $185.7M. Net income increased 42% to $21.6M. Revenues reflect Sales revenue increase of 33% to $167.1M. Net income benefited from Other income (expense) increase from $78K to $994K (income), Interest Income increase from $126K to $468K (income), Interest Expense decrease from $6K (expense) to $0K.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution - NEC
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
SICElectromedical Equipment
SICSurgical And Medical Instruments



  • Poslední aktualizace: 16.12.2017
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Independent Chairman of the BoardHeath Lukatch501.1.2008
President, Chief Executive Officer, DirectorScott Wilkinson521.3.20171.1.2008
Executive Vice President - Finance and Chief Financial Officer, Corporate Secretary and Corporate TreasurerAlison Bauerlein35
Executive Vice President of Sales and MarketingByron Myers371.1.20171.1.2011
Executive Vice President - OperationsMatthew Scribner49
Executive Vice President - EngineeringBrenton Taylor35